Journal Article Summary

The article investigates the effectiveness of a combined treatment for vulvovaginal candidosis (VVC), a common fungal infection affecting the vaginal area. This topic is important because VVC can cause significant discomfort and affect the quality of life for many women. Current treatment guidelines suggest various approaches, including vaginal suppositories and topical creams, but there has been limited research comparing the outcomes of combined treatments versus single treatments.

In the study, 160 women diagnosed with VVC were randomly assigned to receive either a combination of clotrimazol vaginal suppositories and cream or a placebo cream for three days. The researchers assessed the patients at different intervals to measure improvements in symptoms, such as redness and itching. The results showed that those receiving the combination treatment experienced significantly greater reductions in redness and symptoms compared to those using the placebo. Specifically, more patients in the treatment group reported complete relief from itching and burning sensations.

Despite the promising findings, the study has limitations, including its relatively small sample size and the specific population studied, which may not represent all women with VVC. Patients should be aware that while the combination treatment appears more effective, individual responses can vary. It is essential for readers to discuss any treatment options with their healthcare provider to ensure they receive personalized care and to address any concerns regarding their symptoms or treatment effectiveness.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Mendling W., Schlegelmilch R.. Three-Day Combination Treatment for Vulvovaginal Candidosis with 200 mg Clotrimazol Vaginal Suppositories and Clotrimazol Cream for the Vulva is Significantly Better than Treatment with Vaginal Suppositories Alone – an Earlier, Multi-Centre, Placebo-Controlled Double Blind Study. Geburtshilfe und Frauenheilkunde 2014. DOI: 10.1055/s-0034-1368243. PMID: 25076792. PMCID: PMC4078134.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]